Abstract
In recent years intravesical chemotherapy has become accepted worldwide in the treatment of superficial bladder cancer. The main problem treating these patients is the high frequency of recurrences even after complete transurethral resection of all visible lesions (Barnes et al. 1977; Miller et al. 1969). Depending on the grade of the primary tumor recurrences are observed between 50 to 70% (Heney et al. 1982; Dalesio et al. 1983). Concerning the results of randomized studies a maximum of 10 to 20% of the patients will profit from an adjuvant intravesical chemotherapy. More than 70% of the patients are treated unnecessarily (Rübben and Giani 1986). Thus local and systemic side effects as well as late complications of topical chemotherapy have to be considered and weighed against the therapeutic benefit (Lutzeyer et al. 1982).
Preview
Unable to display preview. Download preview PDF.
References
Barnes R, Hadley H, Dick A, Johnston O, Dexter J (1977) Changes in grade and stage of recurrent bladder tumors. J Urol 118: 177–178
Dale GA, Smith RB (1974) Transitional cell carcinoma of the bladder associated with cyclophosphamide. J Urol 112: 603–604
Dalesio O, Schulman CC, Silvester R, Depauw M, Robinson M, Denis L, Smith P, Viggiano G (1983) Prognostic factors in superficial bladder tumors. J Urol 129: 730–733
Daskal Y, Soloway MS, De Furia MD, Crooke ST (1980) Normal mice and mice with N-(4-5-nitro-2-furyl)-2-thiazolyl formamide induced bladder neoplasms. Cancer Res 40: 261
Engelmann U, Burger R, Jacobi GH (1982) Experimental investigations on the absorption of intra-vesically instilled Mitomycin C in the urinary bladder of the rat. Eur Urol 8: 176–181
Frith CH, Wiley LD, Shinohara Y (1982) Sequential morphogenesis of urinary bladder tumors in balb/c mice given 2-acetylaminofluorene. J Urol 128: 1071–1076
Heney NM, Nocks BN, Daly JJ, Prout GR Jr, Newall JB, Griffin PP, Perrone TL, Szyfelbein WA (1982) Ta und T1 bladder cancer: Location, recurrence and progression. Br J Urol 54: 152–157
Hoover R, Fraumeni JF Jr (1981) Drug-induced cancer. Cancer 47: 1071–1080
Jacobi GH, Kurth KH (1980) Topical adriamycin for prophylaxis and treatment of superficial bladder cancer: studies on plasma and tumor uptake. J Urol 124: 34–37
Lutzeyer W, Rubben H, Dahm HH (1982) Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127: 250–252
Miller A, Mitchel JP, Brown NJ (1969) The bristol bladder tumors registry. Br J Urol 41 (Suppl 1): 5–6
Murphy WM, Solo way MS (1980) The effect of thiotepa on developing and established mammalian bladder tumors. Am Can Soc 45: 870
Murphy WM, Soloway MS, Crabtree WN (1981a) The morphologic effects of MMC in mammalian urinary bladder. Cancer 47: 2567–2574
Murphy WM, Soloway MS, Finebaum PJ (1981b) Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 126: 461–464
Okajima E, Hiramatsu T, Hirao K, Ijuin M, Hirao H, Babaya K (1981) Urinary bladder tumors induced by BBN in dogs. Cancer Res 41: 1958
Pavone-Macaluso M, Gebbia N, Biondo S, Caramia G, Rizzo FP (1976) Permeability of the bladder mucosa to thiotepa, adriamycin and daunomycin in mice and rabbits. Urol Res 4: 9–13
Plötz PH, Klippel JH, Decker JL, Grauman D, Wolf B, Brown BC, Rutt G (1979) Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosis or rheumatoid arthritis. Ann Intern Med 91: 221
Pott P (1775) Cancer scroti. In: Hawes, Clark, Collins (eds) Chirurgical observations. London, p 63
Rasmussen K, Peterson BL, Jacobo E, Penick GD, Sal JS (1980) Cytologic effects of thiotepa and adriamycin on normal canine urothelium. Acta cytol 24: 237
Rübben H (1983) Die intravesikale Chemotherapie des Blasenkarzinoms. Experiment und Klinik. Habilitationsschrift vor der Medizinischen Fakultät der RWTH Aachen
Rübben H, Giani G (1986) Experimentelle und klinische Grundlagen der topischen Chemotherapie des Blasenkarzinoms. Manz’scher Buchverlag, Wien
Rübben H, Lutzeyer W (1982) Klinische und experimentelle Gesichtspunkte der intravesikalen Behandlung superfizialer Blasenkarzinome mit Adriamycin. Urologe A 21: 20–23
Wall RL, Clausen KP (1975) Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 293: 271
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Deutz, FJ., Moll, F., Friedrichs, R., Rübben, H., Knüchel, R., Lutzeyer, W. (1987). Long-Term Experimental Study of Intravesical Chemotherapy: Effect on the Normal Urothelium in Dogs. In: Jacobi, G.H., Rübben, H., Harzmann, R. (eds) Investigative Urology 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72735-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-72735-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72737-5
Online ISBN: 978-3-642-72735-1
eBook Packages: Springer Book Archive